Narrative updates are currently in beta.

Back to narrative

Update shared on06 Aug 2025

Fair value Increased 18%
AnalystConsensusTarget's Fair Value
US$85.50
0.6% undervalued intrinsic discount
07 Aug
US$84.97
Loading
1Y
-22.9%
7D
12.2%

The upward revision in Axcelis Technologies’ price target reflects improved revenue growth forecasts and a sharply lower future P/E ratio, leading to a new consensus fair value of $78.50.


What's in the News


  • Issued Q3 2025 guidance: expects approximately $200 million in revenue and $0.87 GAAP EPS.
  • Added to multiple Russell value indexes, including Russell 2000 Value, Russell 2500 Value, Russell 3000 Value, Russell Small Cap Comp Value, and their defensive and extended (3000E) counterparts.

Valuation Changes


Summary of Valuation Changes for Axcelis Technologies

  • The Consensus Analyst Price Target has risen from $72.75 to $78.50.
  • The Consensus Revenue Growth forecasts for Axcelis Technologies has significantly risen from -12.9% per annum to -2.3% per annum.
  • The Future P/E for Axcelis Technologies has significantly fallen from 84.79x to 48.93x.

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.